# A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

> **NCT00277043** · PHASE3 · COMPLETED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 200 (actual)

## Conditions studied

- Supportive
- Ill-defined Sites

## Interventions

- **DRUG:** paclitaxel, docetaxel, taxane
- **DRUG:** taxane

## Key facts

- **NCT ID:** NCT00277043
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2004-07
- **Final completion:** 2005-09
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277043, "A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00277043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*